🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2018-05-14
Trial ID
NCT03522246
Treatments Being Tested
In the subgroup of patients with sarcopenia, regardless of their body mass ...
Status
Completed
Location
Jose Luis Calleja
Start Date
2017-08-01
Trial ID
NCT04073693
Treatments Being Tested
Background: High-grade serous epithelial ovarian cancer is a disease with a...
Status
Recruiting
Location
CHU de Nîmes
Start Date
2020-10-01
Trial ID
NCT06827353
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
This is an open-label, multi-center Phase II study of fluzoparib combined w...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2023-10-18
Trial ID
NCT06063070
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
This research study is a Phase II clinical trial, which tests the safety an...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2013-08
Trial ID
NCT01796197
Treatments Being Tested
The purpose of this study is to find the best and most sensitive screening ...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2006-12
Trial ID
NCT00438906
Treatments Being Tested
The clinical trial is a phase 1, single-arm trial that will evaluate the sa...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2021-01-13
Trial ID
NCT04150042
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095